Loading...
A new alpha in line between KRAS and NF-κB activation?
Bang and colleagues report a novel role for GSK-3α, rather than GSK-3β, as the link between KRAS activating mutations and the canonical and non-canonical activation pathways of NF-κB in pancreatic cancer.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3746833/ https://ncbi.nlm.nih.gov/pubmed/23749528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-13-0193 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|